Stephen Glover
Chief Executive Officer at ZYVERSA THERAPEUTICS, INC.
Net worth: 266 251 $ as of 2024-03-30
Network origin in Stephen Glover first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 26 | |
| Public Company | Pharmaceuticals: Major | 17 | |
| Public Company | Pharmaceuticals: Major | 14 | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.
12
| Subsidiary | Biotechnology | 12 |
11
| Subsidiary | Pharmaceuticals: Major | 11 |
| Public Company | Pharmaceuticals: Major | 10 | |
Andrx Corp.
 Andrx Corp. Pharmaceuticals: MajorHealth Technology Andrx Corp. developed, manufactured, and marketed oral pharmaceutical products. The company was founded in August, 1992 and was headquartered in Davie, FL.
9
| Extinct | Pharmaceuticals: Major | 9 |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Wallace H. Coulter Foundation
3
| Foundation/Endowment | Miscellaneous Commercial Services | 3 |
Asclepius Life Sciences Fund LP
 Asclepius Life Sciences Fund LP Financial ConglomeratesFinance Asclepius Life Sciences Fund LP provides pooled investment funds. The company was founded by Stephen C. Glover and Steven Gerst and is headquartered in New York, NY.
1
| Private Company | Financial Conglomerates | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stephen Glover via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Medical Specialties | Director/Board Member Chief Operating Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin Graduate Degree | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Founder Director of Finance/CFO | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Founder | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Compliance Officer | |
| University of Virginia | College/University | Masters Business Admin Doctorate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Graduate Degree Corporate Officer/Principal | |
| Boston University | College/University | Director of Finance/CFO Undergraduate Degree Masters Business Admin | |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President Sales & Marketing | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| NETSCIENTIFIC PLC | Medical Specialties | Chairman Chief Executive Officer | |
| 4D PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts College of Pharmacy & Health Science | College/University | Graduate Degree Undergraduate Degree | |
| SEELOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Rosemont College | College/University | Undergraduate Degree Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Doctorate Degree | |
| The University of Chicago | College/University | Undergraduate Degree Graduate Degree | |
| New York University | College/University | Graduate Degree Graduate Degree | |
| Saint Peter's University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Undergraduate Degree | |
| THERAPEUTICSMD, INC. | Pharmaceuticals: Major | Founder Director/Board Member |
Statistics
International
| United States | 45 |
| United Kingdom | 4 |
| China | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Health Services | 2 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 329 |
| Corporate Officer/Principal | 207 |
| Chairman | 91 |
| Independent Dir/Board Member | 91 |
| Chief Executive Officer | 84 |
Most connected contacts
| Insiders | |
|---|---|
| Richard Ferrari | 43 |
| Richard Sykes | 36 |
| James Sapirstein | 26 |
| Paul Maier | 25 |
| DeLyle Bloomquist | 25 |
| Donald Hayden | 23 |
| Eric Richman | 22 |
| Daniel O'Connor | 22 |
| Mats Wahlström | 22 |
| Anthony Giovinazzo | 22 |
| Graham K. Crooke | 21 |
| Kamil Ali-Jackson | 21 |
| Ilian Iliev | 21 |
| S. Torres | 21 |
| August Troendle | 16 |
- Stock Market
- Insiders
- Stephen Glover
- Company connections
